CR
Christine Ring
Chief Legal Officer

Christine Ring insider trades: Nurix Therapeutics (NRIX) stock sales

Chief Legal Officer, Nurix Therapeutics Last trade Nov 3, 2026 69 Form 4 filings
$3.2M
Sold, last 12 months
17 sales
$0
Bought, last 12 months
0 buys
62
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christine reports to the SEC

Open-market buys and sales

62 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 3, 2026NRIX↓ Sell$432K
Oct 30, 2026NRIX↓ Sell$104K
Oct 2, 2026NRIX↓ Sell$134K
Sep 2, 2026NRIX↓ Sell$149K
Aug 3, 2026NRIX↓ Sell$382K
Jul 30, 2026NRIX↓ Sell$90K
Jul 2, 2026NRIX↓ Sell$259K
Jun 2, 2026NRIX↓ Sell$135K
May 4, 2026NRIX↓ Sell$138K
Apr 30, 2026NRIX↓ Sell$53K
Apr 2, 2026NRIX↓ Sell$124K
Mar 2, 2026NRIX↓ Sell$126K
Feb 9, 2026NRIX↓ Sell$238K
Jan 30, 2026NRIX↓ Sell$73K
Jan 20, 2026NRIX↓ Sell$69K
Dec 18, 2025NRIX↓ Sell$67K
Nov 24, 2025NRIX↓ Sell$642K
Oct 30, 2025NRIX↓ Sell$47K
Jul 30, 2025NRIX↓ Sell$46K
Apr 30, 2025NRIX↓ Sell$33K
Jan 31, 2025NRIX↓ Sell$115K
Jan 30, 2025NRIX↓ Sell$64K
Jan 2, 2025NRIX↓ Sell$112K
Dec 2, 2024NRIX↓ Sell$125K
Nov 4, 2024NRIX↓ Sell$82K
Nov 1, 2024NRIX↓ Sell$140K
Oct 30, 2024NRIX↓ Sell$102K
Oct 14, 2024NRIX↓ Sell$82K
Oct 1, 2024NRIX↓ Sell$128K
Sep 3, 2024NRIX↓ Sell$226K
Aug 26, 2024NRIX↓ Sell$247K
Aug 1, 2024NRIX↓ Sell$123K
Jul 30, 2024NRIX↓ Sell$60K
Jul 1, 2024NRIX↓ Sell$120K
Jun 13, 2024NRIX↓ Sell$32K
Jun 12, 2024NRIX↓ Sell$32K
Jun 5, 2024NRIX↓ Sell$7K
Jun 3, 2024NRIX↓ Sell$27K
Apr 30, 2024NRIX↓ Sell$18K
Jan 30, 2024NRIX↓ Sell$14K
Oct 31, 2023NRIX↓ Sell$6K
Jul 31, 2023NRIX↓ Sell$14K
May 1, 2023NRIX↓ Sell$7K
Jan 30, 2023NRIX↓ Sell$10K
Oct 31, 2022NRIX↓ Sell$9K
Aug 1, 2022NRIX↓ Sell$11K
May 2, 2022NRIX↓ Sell$8K
Jan 10, 2022NRIX↓ Sell$33K
Dec 10, 2021NRIX↓ Sell$35K
Nov 10, 2021NRIX↓ Sell$39K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NRIX insiders

Open-market trades in the last 12 months

About Christine Ring's insider trades

Christine Ring is Chief Legal Officer at Nurix Therapeutics (NRIX). Since Feb 18, 2021, Christine has reported no open-market purchases and 62 sales worth $6.0M on SEC Form 4. In the last 12 months: 17 sales ($3.2M).

Their filings also include option exercises (58 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NRIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.